KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CareDx (CDNA) EBITDA Margin (2016 - 2025)

CareDx's EBITDA Margin history spans 13 years, with the latest figure at 5.57% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 9184.0% year-over-year to 5.57%; the TTM value through Dec 2025 reached 8.1%, down 1838.0%, while the annual FY2025 figure was 8.1%, 2032.0% down from the prior year.
  • EBITDA Margin for Q4 2025 was 5.57% at CareDx, down from 0.25% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 86.27% in Q4 2024 and bottomed at 354.15% in Q2 2023.
  • The 5-year median for EBITDA Margin is 18.0% (2021), against an average of 37.53%.
  • The largest annual shift saw EBITDA Margin crashed -32722bps in 2023 before it skyrocketed 34971bps in 2024.
  • A 5-year view of EBITDA Margin shows it stood at 19.44% in 2021, then dropped by -19bps to 23.21% in 2022, then crashed by -706bps to 187.03% in 2023, then surged by 146bps to 86.27% in 2024, then tumbled by -106bps to 5.57% in 2025.
  • Per Business Quant, the three most recent readings for CDNA's EBITDA Margin are 5.57% (Q4 2025), 0.25% (Q3 2025), and 12.83% (Q2 2025).